Home > Search Results

Results: 4

Comparing newer drugs for diabetes, including combination drugs

How do newer drugs for diabetes compare in lowering blood sugar levels?

PubMed Clinical Q&A [Internet] - National Center for Biotechnology Information (US).

Version: May 16, 2011

Medicines for Type 2 Diabetes: A Review of the Research for Adults

This summary covers the research on the benefits and possible side effects of medicines to lower or control your blood sugar. It will help you talk with your doctor or other health care professional to decide which medicines are best for you.

Comparative Effectiveness Review Summary Guides for Consumers [Internet] - Agency for Healthcare Research and Quality (US).

Version: June 30, 2011

Comparing Thiazolidinediones

How do thiazolidinediones compare in lowering blood sugar levels?

PubMed Clinical Q&A [Internet] - National Center for Biotechnology Information (US).

Version: September 1, 2009

Glucagon‐like peptide analogues for type 2 diabetes

Glucagon‐like peptide analogues or agonists are a new kind of drug in the treatment of type 2 diabetes that are given by injection under the skin. They regulate glucose levels by stimulating glucose‐dependent insulin secretion and biosynthesis, and by suppressing glucagon secretion, delaying gastric emptying and promoting satiety.  Various glucagon‐like peptide‐1 agonists are in use or in the licensing process, including exenatide, liraglutide, albiglutide, taspoglutide, lixisenatide and LY2189265.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2013

Systematic Reviews in PubMed

See all (9)...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...